Medical Aesthetic Devices: Technologies and Global Markets

Published by: BCC Research

Published: Apr. 1, 2011 - 238 Pages

Table of Contents

CHAPTER ONE: INTRODUCTION

STUDY GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

SCOPE OF REPORT

INTENDED AUDIENCE

METHODOLOGY AND INFORMATION SOURCES

ANALYST CREDENTIALS

RELATED BCC REPORTS

BCC ONLINE SERVICES

DISCLAIMER

CHAPTER TWO: SUMMARY

SUMMARY

SUMMARY TABLE 1 GLOBAL DEMAND FOR MEDICAL AESTHETIC DEVICES BY REGION, THROUGH 2015 ($ MILLIONS)

SUMMARY FIGURE GLOBAL DEMAND FOR MEDICAL AESTHEIC DEVICES BY REGION, 2009-2015 ($ MILLIONS)

SUMMARY TABLE 2 GLOBAL DEMAND FOR MEDICAL AESTHETIC DEVICES BY TECHNOLOGY, 2009-2015 ($ MILLIONS)

CHAPTER THREE: INDUSTRY OVERVIEW

PRACTITIONERS

TABLE 1 U.S. PHYSICIANS BY SPECIALTY, 2009

MEDICAL SOCIETIES

PATIENTS

SEX DISTRIBUTION

AGE DISTRIBUTION

INCOME DISTRIBUTION

TABLE 2 MIDDLE- AND UPPER-INCOME WOMEN BY REGION, 2009-2015 (MILLIONS)

SURGERY VERSUS MINIMAL INVASIVENESS

MEDICAL TOURISM

INDUSTRY INTEGRATION

TABLE 3 HORIZONTAL INTEGRATION OF INJECTABLES MANUFACTURERS

TABLE 4 HORIZONTAL INTEGRATION OF LASER DEVICE MANUFACTURERS

COMBINATION TREATMENTS

PATIENT COMFORT

HAND REJUVENATION

CHAPTER FOUR: PROPERTIES OF HUMAN SKIN

SKIN LAYERS

HYPODERMIS

DERMIS

EPIDERMIS

COMPONENTS OF SKIN TISSUE

COLLAGEN

ELASTIN

HYALURONIC ACID

FITZPATRICK SCALE

TABLE 5 FITZPATRICK SKIN PHOTOTYPES

FACIAL ANATOMY

MUSCLES

WRINKLES

CHAPTER FIVE: REGULATORY ASPECTS

UNITED STATES

MEDICAL DEVICES

Premarket Approval

Pre-Market Notification

Investigational Device Exemption

Post-Market Surveillance

Quality System Regulation

Device Modifications

Adverse Events Reporting

BIOLOGICAL LICENSE APPLICATION

LASER SAFETY

OFF-LABEL USE

INTERNATIONAL STANDARDS

EUROPEAN UNION

DRUGS

JAPAN

CHINA

OTHER COUNTRIES

CHAPTER SIX: BOTULINUM NEUROMODULATORS

DESCRIPTION

HISTORY

MARKET OVERVIEW

TABLE 6 BOTULINUM MODULATORS ON THE GLOBAL MARKET

MANUFACTURING

TABLE 7 MATERIAL CHARACTERISTICS OF BOTULINUM PRODUCTS

DISTRIBUTION AND PACKAGING

APPLICATION

TABLE 8 TYPICAL DOSES USED IN BOTOX TREATMENTS

EFFECTS

FACTORS DRIVING GROWTH

GEOGRAPHIC DISTRIBUTION

TABLE 9 FEMALE POPULATION AGE 35 TO 65, 2010 AND 2015 (MILLIONS)

TABLE 10 GLOBAL MARKET FORECAST FOR BOTULINUM TOXIN BY REGION, THROUGH 2015 (THOUSANDS)

TABLE 11 GLOBAL MARKET FORECAST FOR BOTULINUM TOXIN SALES BY REGION, THROUGH 2015 ($ MILLIONS)

SKIN TYPE PREVALENCE

NEW APPLICATIONS

PRICE

FACTORS INHIBITING GROWTH

SAFETY

FAKE BOTOX

REGULATORY

PRODUCTION CAPACITY

TERRORIST ACTIVITY

PRODUCT PIPELINE

NEW FORMULATIONS

PurTox

Neuronox

RT001 and RT002

NEW PRODUCTS

CRYO-TOUCH

NEW DRUGS

TABLE 12 PATENTS RELATED TO BTX PRODUCTION AND FORMULATION METHODS

TABLE 13 PATENTS RELATED TO NEW USES AND DELIVERY

MODES OF BTX PRODUCTS

TABLE 14 PATENTS RELATED TO REPLACEMENTS FOR BTX

TABLE 15 OTHER BOTULINUM PATENTS

CHAPTER SEVEN: DERMAL FILLERS

POLY-L-LACTIC ACID

HISTORY

DESCRIPTION

APPLICATION

COST

DEMOGRAPHICS

CALCIUM HYDROXYLAPATITE

HISTORY

DESCRIPTION

APPLICATION

COST

DEMOGRAPHICS

COLLAGEN

HISTORY

DESCRIPTION

TABLE 16 COLLAGEN-BASED DERMAL FILLERS

APPLICATION

COST

HYALURONIC ACID

HISTORY

TABLE 17 HYALURONIC ACID MANUFACTURERS

DESCRIPTION

PRODUCT OVERVIEW

APPLICATION

COST

DEMOGRAPHICS

PERMANENT FILLERS

TABLE 18 PROPERTIES OF AN IDEAL NON-ABSORBABLE FILLER

Polyacrylamide

Polyalkylimide

Bioplastique (Uroplasty)

Silicone

Polymethylmethacrylate

Gore-Tex

Laresse

PRODUCT PIPELINE

EPLICA

KYTHERA

LAVIV

NOVABEL

EMERVEL

FACTORS AFFECTING GROWTH

REGULATORY

U.S.

Europe

COST

DURATION

TABLE 19 COMPARATIVE COSTS OF DERMAL FILLERS ($)

QUALITY

SAFETY

TABLE 20 DERMAL FILLER INJURIES REPORTED TO THE FDA, 2009 AND 2010

AGE PROGRESSION

FORECAST BY REGION

TABLE 21 DERMAL FILLER REVENUES BY TECHNOLOGY, THROUGH 2015 ($ MILLIONS)

TABLE 22 DERMAL FILLER REVENUES BY REGION, THROUGH 2015 ($ MILLIONS)

TABLE 23 U.S. DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

TABLE 24 BRAZIL DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

TABLE 25 CHINA DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

TABLE 26 INDIA DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

TABLE 27 MEXICO DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

TABLE 28 JAPAN DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

TABLE 29 EUROPE DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

TABLE 30 REST OF WORLD DERMAL FILLER REVENUES, THROUGH 2015 ($ MILLIONS)

FORECAST BY MATERIAL

TABLE 31 POLY-L-LACTIC ACID DERMAL FILLER REVENUES BY REGION, THROUGH 2015 ($ MILLIONS)

TABLE 32 COLLAGEN DERMAL FILLER REVENUES BY REGION, THROUGH 2015 ($ MILLIONS)

TABLE 33 CALCIUM HYDROXYLAPATITE DERMAL FILLER REVENUES BY REGION, THROUGH 2015 ($ MILLIONS)

TABLE 34 HYALURONIC ACID DERMAL FILLER REVENUES BY REGION, THROUGH 2015 ($ MILLIONS)

TABLE 35 PERMANENT DERMAL FILLER REVENUES BY REGION, THROUGH 2015 ($ MILLIONS)

PATENTS

TABLE 36 PATENTS FOR CALCIUM HYDROXLYAPATITE

TABLE 37 PATENTS FOR HYALURONIC ACID

TABLE 38 PATENTS FOR PERMANENT DERMAL FILLERS

TABLE 39 PATENTS FOR OTHER DERMAL FILLERS

CHAPTER EIGHT: BREAST AUGMENTATION

STRUCTURE OF THE BREAST

EARLY ATTEMPTS

SILICON AND SILICONE

IMPLANT STRUCTURE

IMPLANT SHAPES

SILICONE LITIGATION

TABLE 40 MEDICAL ORGANIZATIONS’ COMMENTS REGARDING THE SAFETY OF SILICONE IMPLANTS

PLATINUM

IMPLANT PROCEDURE

PHYSICIAN/FACILITY

ANESTHESIA

INCISION

IMPLANT PLACEMENT

DOWNTIME

COMPLICATIONS

Capsular Contracture

Synmastia

Bottoming Out

Infection

Rippling

Silent Rupture

Mammography

Breastfeeding

LONGEVITY OF RESULTS

TABLE 41 COMPARISON OF SALINE-FILLED AND SILICONE GELFILLED IMPLANTS (%)

GUMMY BEAR IMPLANTS

TABLE 42 MANUFACTURERS OF HIGH-COHESIVE SILICONE GEL IMPLANTS

MACROLANE

BREFORM

OTHER BODY IMPLANTS

EPLICA

MARKET OVERVIEW

TABLE 43 PRODUCERS OF SALINE BREAST IMPLANTS

TABLE 44 PRODUCERS OF SILICONE BREAST IMPLANTS

COST

INSURANCE COVERAGE

WARRANTY

MATERIAL

REGULATORY

U.S.

ANAPLASTIC LARGE CELL LYMPHOMA

Globally

DEMOGRAPHICS

CULTURE

PATIENT INPUT

FORECAST BY REGION

TABLE 45 GLOBAL DEMAND FOR BREAST AUGMENTATION DEVICES, THROUGH 2015 ($ MILLIONS)

FORECAST BY TECHNOLOGY

TABLE 46 SALINE-FILLED BREAST IMPLANTS AMONG ALL BREAST IMPLANTS, 2009-2015 (%)

TABLE 47 GLOBAL DEMAND FOR SALINE-FILLED BREAST IMPLANTS, THROUGH 2015 ($ MILLIONS)

TABLE 48 GLOBAL DEMAND FOR SILICONE GEL-FILLED BREAST IMPLANTS, THROUGH 2015 ($ MILLIONS)

TABLE 49 GLOBAL DEMAND FOR GUMMY BEAR BREAST IMPLANTS, THROUGH 2015 ($ MILLIONS)

TABLE 50 GLOBAL DEMAND FOR MACROLANE BREAST INJECTIONS, THROUGH 2015 ($ MILLIONS)

PATENTS

TABLE 51 PATENTS FOR COHESIVE-GEL IMPLANTS

TABLE 52 PATENTS FOR TEXTURED SURFACES

TABLE 53 OTHER BREAST IMPLANT PATENTS

CHAPTER NINE: EXTERNAL ENERGY-EMITTING DEVICES

APPLICATIONS OF DEVICES

TABLE 54 EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 55 EEED PROCEDURES BY REGION, THROUGH 2015 (THOUSANDS)

TABLE 56 U.S. EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 57 BRAZIL EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 58 CHINA EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 59 INDIA EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 60 MEXICO EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 61 JAPAN EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 62 EUROPE EEED LASER PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

TABLE 63 REST OF WORLD EEED PROCEDURES BY APPLICATION, THROUGH 2015 (THOUSANDS)

HAIR REMOVAL

Hair Structure and Growth

Principle of Operation

TABLE 64 DEVICES FOR HAIR REMOVAL

History

Treatment

ABLATIVE SKIN RESURFACING

Principle of Operation

Treatment

TABLE 65 DEVICES FOR ABLATIVE SKIN RESURFACING

NON-ABLATIVE SKIN RESURFACING

TABLE 66 DEVICES FOR NON-ABLATIVE SKIN RESURFACING

VASCULAR LESIONS

Varicose Veins

Principle of Operation

Procedure

TABLE 67 DEVICES FOR VASCULAR LESIONS

Demographics

SKIN TIGHTENING

TABLE 68 DEVICES FOR SKIN TIGHTENING

TATTOO REMOVAL

TABLE 69 DEVICES FOR TATTOO REMOVAL

ACNE

TABLE 70 DEVICES FOR ACNE TREATMENT

PIGMENTED LESIONS

TABLE 71 DEVICES FOR THE TREATMENT OF PIGMENTED LESIONS

CELLULITE

TABLE 72 DEVICES FOR THE TREATMENT OF CELLULITE

TYPES OF DEVICES

LASERS

Properties of Laser Light

Principle of Operation

Application

TABLE 73 EEED LIGHT SOURCES (NM)

Q-Switching

Thulium Lasers

Neodymium-Yttrium Aluminum Garnet Lasers

Erbium Lasers

Yttrium-Scandium-Gallium Garnet Lasers

Diode Lasers

Potassium Titanyl Phosphate

Carbon Dioxide Lasers

Ruby Lasers

Dye Lasers

Alexandrite Lasers

LIGHT-EMITTING DIODES

FLASHLAMPS

RADIOFREQUENCY

ELÔS

SPOT SIZE

FRACTIONAL DEVICES

EPIDERMAL COOLING

MARKET OVERVIEW

MODULARITY

CONSUMABLES

TABLE 74 EEED PRINCIPAL CONSUMABLES, 2010 ($ MILLIONS)

OVER-THE-COUNTER DEVICES

TABLE 75 FDA-CLEARED OVER-THE-COUNTER EEEDS

MARKETING

TABLE 76 EEED MANUFACTURERS, 2009-2010 ($ MILLIONS)

ALMA LASERS

TABLE 77 ALMA LASERS EEED PRODUCTS

CUTERA

TABLE 78 CUTERA EEED PRODUCTS

CYNOSURE

TABLE 79 CYNOSURE EEED PRODUCTS

IRIDEX

TABLE 80 IRIDEX EEED PRODUCTS

LUMENIS

TABLE 81 LUMENIS EEED PRODUCTS

PALOMAR MEDICAL

TABLE 82 PALOMAR MEDICAL EEED PRODUCTS

SOLTA MEDICAL

TABLE 83 SOLTA MEDICAL EEED PRODUCTS

SYNERON

TABLE 84 SYNERON EEED PRODUCTS

REGULATORY ISSUES

SAFETY

FORECAST BY CATEGORY AND TECHNOLOGY

CORE MARKET

NON-CORE MARKETS

NEW UNIT SALES

UPGRADE SALES

SYSTEM LEASING

CONSUMABLE SALES

TABLE 85 EEED MARKET BY TECHNOLOGY, THROUGH 2015 ($ MILLIONS)

TABLE 86 EEED MARKET BY CATEGORY, THROUGH 2015 ($ MILLIONS)

FORECAST BY GEOGRAPHY

TABLE 87 EEED MARKET, THROUGH 2015 ($ MILLIONS)

TABLE 88 EEED NEW UNITS MARKET BY REGION, THROUGH 2015 ($ MILLIONS)

TABLE 89 EEED MARKET UPGRADES BY REGION, THROUGH 2015 ($ MILLIONS)

TABLE 90 EEED CONSUMABLES MARKET BY REGION, THROUGH 2015 ($ MILLIONS)

PRODUCT PIPELINE

NEW TECHNOLOGY

PATENTS

FRACTIONAL TECHNOLOGY OPEN PATENT PROGRAM

TABLE 91 PATENTS AND PATENT APPLICATIONS FOR FRACTIONAL METHODS

TABLE 92 PATENTS FOR HAIR REMOVAL

TABLE 93 PATENTS FOR EPIDERMAL COOLING

TABLE 94 PATENTS FOR WRINKLE REDUCTION

TABLE 95 PATENTS INVOLVING ACNE, SKIN LESIONS, AND TATTOOS

TABLE 96 PATENTS FOR RADIOFREQUENCY METHODS

TABLE 97 OTHER EEED PATENTS

CHAPTER TEN: DEVICES FOR ASSISTED LIPOSUCTION

TABLE 98 GLOBAL OVERWEIGHT ADULT FEMALE POPULATION, 2010-2015 (MILLIONS)

STRUCTURE OF FAT

EARLY ATTEMPTS

SUITABILITY FOR LIPOSUCTION

TRADITIONAL PROCEDURE (SAL/PAL)

COMPLICATIONS AND SIDE EFFECTS

ULTRASOUND-ASSISTED LIPOSUCTION

LASER-ASSSTED LIPOSUCTION

WATER-ASSISTED LIPOSUCTION

TABLE 99 MANUFACTURERS OF LIPOSUCTION DEVICES

DEMOGRAPHICS

COMPARISON OF METHODS

COST

RESULTS

FORECAST BY REGION

TABLE 100 GLOBAL LIPOSUCTION PROCEDURES BY REGION, THROUGH 2015 (THOUSANDS)

TABLE 101 GLOBAL DEMAND FOR ASSISTIVE LIPOSUCTION DEVICES BY REGION, THROUGH 2015 ($ MILLIONS)

FORECAST BY TECHNOLOGY

TABLE 102 GLOBAL LIPOSUCTION PROCEDURES BY TECHNOLOGY, THROUGH 2015 (THOUSANDS)

TABLE 103 GLOBAL DEMAND FOR ASSISTIVE LIPOSUCTION DEVICES BY TECHNOLOGY, THROUGH 2015 ($ MILLIONS)

PRODUCT PIPELINE

FAT TRANSFER

HIGH-INTENSITY FOCUSED ULTRASOUND

INJECTION LIPOLYSIS

PATENTS

TABLE 104 PATENTS FOR LASER-ASSISTED LIPOSUCTION

TABLE 105 PATENTS FOR ULTRASOUND-ASSISTED LIPOSUCTION

TABLE 106 PATENTS FOR WATER-ASSISTED LIPOSUCTION

TABLE 107 OTHER ASSISTED-LIPOSUCTION PATENTS

CHAPTER ELEVEN: COMPANY PROFILES

ALCON, INC.

ALLERGAN, INC.

ALMA LASERS, LTD.

ANIKA THERAPEUTICS, INC

ANTEIS SA

BIOCOMPATIBLES INTERNATIONAL

BIOFORM MEDICAL, INC.

BIOSIL, LTD.

BREFORM LIMITED

CONTURA INTERNATIONAL A/S

CRISALIX S.A.

CUTERA

CYNOSURE, INC.

DEKA LASER

EL.EN. GROUP

ETHICON

EUROSILICONE S.A.S.

FIBROCELL SCIENCE, INC.

FOCUS MEDICAL

FZIOMED, INC.

GALDERMA PHARMA SA/GALDERMA SA

GENZYME CORPORATION

GLOBAL CONSOLIDATED AESTHETICS, LTD.

HOYA CONBIO

HUMAN MED AG

IPSEN PHARMA

IRIDEX CORP.

JOHNSON & JOHNSON

LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS

LASERING

LCA PHARMACEUTICAL

LUMENIS, LTD.

LUTRONIC, INC.

MEDICIS PHARMACEUTICAL CORP.

MEDICIS TECHNOLOGIES CORPORATION

MEDY-TOX, INC.

MENTOR WORLDWIDE LLC

MERZ GMBH & CO. KGAA

MISONIX, INC.

MYOSCIENCE INC.

NAGOR, LTD.

OSYRIS MEDICAL

PALOMAR MEDICAL TECHNOLOGIES, INC.

PHAROS LIFE CORPORATION

POLYMEKON S.R.L.

PROLLENIUM MEDICAL TECHNOLOGIES, INC.

Q-MED AB

REVANCE THERAPEUTICS, INC.

SANOFI-AVENTIS U.S., LLC

SCITON, INC.

SEBBIN (LABORATOIRES SEBBIN)

SIENTRA, INC.

SILIMED LTDA.

SOLSTICE NEUROSCIENCES, LLC

SOLTA MEDICAL, INC.

SOERING GMBH MEDIZINTECHNIK

SOUND SURGICAL TECHNOLOGIES, LLC

STIEFEL LABORATORIES, INC.

SUNEVA MEDICAL, INC.

SYNERON MEDICAL, LTD.

SYNOPTICS (NORTHROP GRUMMAN SYNOPTICS)

TEOXANE (LABORATOIRES TEOXANE)

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.